TCMD Quote, Financials, Valuation and Earnings

Accuray, Inc. has a net margin of 10.27% compared to Tactile Systems Technology, Inc.'s net margin of -13.47%. Tactile Systems Technology, Inc.'s return on equity of 9.17% beat Accuray, Inc.'s return on equity of -60.6%.

Tactile Systems Technology, Inc. has a consensus price target of $38.00, signalling upside risk potential of 14.98%. On the other hand Accuray, Inc. has an analysts' consensus of $2.53 which suggests that it could grow by 372.4%. Given that Accuray, Inc. has higher upside potential than Tactile Systems Technology, Inc., analysts believe Accuray, Inc. is more attractive than Tactile Systems Technology, Inc..

Tactile Systems Technology, Inc. has a beta of 0.960, which suggesting that the stock is 3.951% less volatile than S&P 500. In comparison Accuray, Inc. has a beta of 1.151, suggesting its more volatile than the S&P 500 by 15.124%.

Tactile Systems Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Accuray, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tactile Systems Technology, Inc. pays -- of its earnings as a dividend. Accuray, Inc. pays out -- of its earnings as a dividend.

Tactile Systems Technology, Inc. quarterly revenues are $103.6M, which are larger than Accuray, Inc. quarterly revenues of $102.2M. Tactile Systems Technology, Inc.'s net income of $10.6M is higher than Accuray, Inc.'s net income of -$13.8M. Notably, Tactile Systems Technology, Inc.'s price-to-earnings ratio is 39.39x while Accuray, Inc.'s PE ratio is 149.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tactile Systems Technology, Inc. is 2.32x versus 0.14x for Accuray, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Alphatec Holdings, Inc. has a net margin of 10.27% compared to Tactile Systems Technology, Inc.'s net margin of -14.54%. Tactile Systems Technology, Inc.'s return on equity of 9.17% beat Alphatec Holdings, Inc.'s return on equity of -1495.13%.

Tactile Systems Technology, Inc. has a consensus price target of $38.00, signalling upside risk potential of 14.98%. On the other hand Alphatec Holdings, Inc. has an analysts' consensus of $24.62 which suggests that it could grow by 81.8%. Given that Alphatec Holdings, Inc. has higher upside potential than Tactile Systems Technology, Inc., analysts believe Alphatec Holdings, Inc. is more attractive than Tactile Systems Technology, Inc..

Tactile Systems Technology, Inc. has a beta of 0.960, which suggesting that the stock is 3.951% less volatile than S&P 500. In comparison Alphatec Holdings, Inc. has a beta of 1.013, suggesting its more volatile than the S&P 500 by 1.34%.

Tactile Systems Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tactile Systems Technology, Inc. pays -- of its earnings as a dividend. Alphatec Holdings, Inc. pays out -- of its earnings as a dividend.

Tactile Systems Technology, Inc. quarterly revenues are $103.6M, which are smaller than Alphatec Holdings, Inc. quarterly revenues of $196.5M. Tactile Systems Technology, Inc.'s net income of $10.6M is higher than Alphatec Holdings, Inc.'s net income of -$28.6M. Notably, Tactile Systems Technology, Inc.'s price-to-earnings ratio is 39.39x while Alphatec Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tactile Systems Technology, Inc. is 2.32x versus 2.76x for Alphatec Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Boston Scientific Corp. has a net margin of 10.27% compared to Tactile Systems Technology, Inc.'s net margin of 12.68%. Tactile Systems Technology, Inc.'s return on equity of 9.17% beat Boston Scientific Corp.'s return on equity of 12.55%.

Tactile Systems Technology, Inc. has a consensus price target of $38.00, signalling upside risk potential of 14.98%. On the other hand Boston Scientific Corp. has an analysts' consensus of $104.78 which suggests that it could grow by 37.36%. Given that Boston Scientific Corp. has higher upside potential than Tactile Systems Technology, Inc., analysts believe Boston Scientific Corp. is more attractive than Tactile Systems Technology, Inc..

Tactile Systems Technology, Inc. has a beta of 0.960, which suggesting that the stock is 3.951% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.441%.

Tactile Systems Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tactile Systems Technology, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.

Tactile Systems Technology, Inc. quarterly revenues are $103.6M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. Tactile Systems Technology, Inc.'s net income of $10.6M is lower than Boston Scientific Corp.'s net income of $670M. Notably, Tactile Systems Technology, Inc.'s price-to-earnings ratio is 39.39x while Boston Scientific Corp.'s PE ratio is 39.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tactile Systems Technology, Inc. is 2.32x versus 5.68x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Plus Therapeutics, Inc. has a net margin of 10.27% compared to Tactile Systems Technology, Inc.'s net margin of -316.61%. Tactile Systems Technology, Inc.'s return on equity of 9.17% beat Plus Therapeutics, Inc.'s return on equity of --.

Tactile Systems Technology, Inc. has a consensus price target of $38.00, signalling upside risk potential of 14.98%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $5.50 which suggests that it could grow by 1843.46%. Given that Plus Therapeutics, Inc. has higher upside potential than Tactile Systems Technology, Inc., analysts believe Plus Therapeutics, Inc. is more attractive than Tactile Systems Technology, Inc..

Tactile Systems Technology, Inc. has a beta of 0.960, which suggesting that the stock is 3.951% less volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.886, suggesting its less volatile than the S&P 500 by 11.364%.

Tactile Systems Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tactile Systems Technology, Inc. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.

Tactile Systems Technology, Inc. quarterly revenues are $103.6M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. Tactile Systems Technology, Inc.'s net income of $10.6M is higher than Plus Therapeutics, Inc.'s net income of -$4.4M. Notably, Tactile Systems Technology, Inc.'s price-to-earnings ratio is 39.39x while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tactile Systems Technology, Inc. is 2.32x versus 4.54x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.